Australian regulator TGA warns of ‘rare but severe’ eye disorder linked to GLP-1 drugs like Ozempic

Australia’s Therapeutic Goods Administration (TGA) has issued warnings for diabetes and weight loss drugs like Ozempic, Wegovy, and Mounjaro, linking them to 36 cases of a rare but severe eye disorder called NAION that could cause blindness. The TGA updated product information to include this health risk.